key: cord-0325638-kzpl3cwk
authors: Prescott, Lucas
title: SARS-CoV-2 PLpro whole human proteome cleavage prediction and enrichment/depletion analysis
date: 2021-10-06
journal: bioRxiv
DOI: 10.1101/2021.10.04.462902
sha: b99dd9ff46d6ab2f5febdccfcfcbeff5711fb328
doc_id: 325638
cord_uid: kzpl3cwk

A novel coronavirus (SARS-CoV-2) has caused a pandemic that has killed millions of people, worldwide vaccination and herd immunity are still far away, and few therapeutics are approved by regulatory agencies for widespread use. The coronavirus 3-chymotrypsin-like protease (3CLpro) is a commonly investigated target in COVID-19, however less work has been directed toward the equally important papain-like protease (PLpro). PLpro is less characterized due to its fewer and more diverse cleavages in coronavirus proteomes and the assumption that it mainly modulates host pathways with its deubiquitinating activity. Here, I extend my previous work on 3CLpro human cleavage prediction and enrichment/depletion analysis to PLpro.[1] Using three sets of neural networks trained on different taxonomic ranks of dataset with a maximum of 463 different putative PLpro cleavages, Matthews correlation coefficients of 0.900, 0.948, and 0.966 were achieved for Coronaviridae, Betacoronavirus, and Sarbecovirus, respectively. I predict that more than 1,000 human proteins may be cleaved by PLpro depending on diversity of the training dataset and that many of these proteins are distinct from those previously predicted to be cleaved by 3CLpro. PLpro cleavages are similarly nonrandomly distributed and result in many annotations shared with 3CLpro cleavages including ubiquitination, poly(A) tail and 5’ cap RNA binding proteins, helicases, and endogenous viral proteins. Combining PLpro with 3CLpro cleavage predictions, additional novel enrichment analysis was performed on known substrates of cleaved E3 ubiquitin ligases with results indicating that many pathways including viral RNA sensing are affected indirectly by E3 ligase cleavage independent of traditional PLpro deubiquitinating activity. As with 3CLpro, PLpro whole proteome cleavage prediction revealed many novel potential therapeutic targets against coronaviruses, although experimental verification is similarly required.

before nsp2, (4) all gamma-and deltacoronaviruses are missing a cleavage before nsp2, or (5) position and not the P2 position as hinted by many sequences aligned here, particularly nsp1/2 105 cleavages ( Figure 2 ). Molecular docking or crystallography are, however, required to prove these 106 chemical similarities relevant. Additionally complicating the problem, dimensionality reduction of 107 putative cleavages did not cluster by order as well as for 3CLpro, and nsp1/2 cleavages missing from all 108 gamma-and deltacoronaviruses have a distinct sequence logo ( Figure 2 Sarbecovirus, respectively. These accuracies, frequency cleaving random amino acid sequences, and 148 number of human proteins with predicted cleavages are also listed in Table 1 . Enrichments and depletions were surprisingly shared between NN replicates, resampled training 158 data, and between the three taxonomic ranks of training data, although the Sarbecovirus-specific list 159 returned fewer statistically significant annotations due to its smaller size. As expected from SARS-CoV-2 160 pathogenesis and from previous 3CLpro results,[1] epithelium (tongue, larynx, pharynx, trachea) and 161 brain were enriched, and olfactory receptors were depleted. As expected from the sequence logo, 162

glycine-and alanine-rich proteins, such as collagens, were also enriched. Cytoskeletal and motor 163

proteins were enriched as with 3CLpro due to their longer lengths, although their cleavage is likely still 164 biologically relevant. In fact, this length bias is even larger in Reynolds et al. ' 

Structural basis for the ubiquitin-linkage 396 specificity and deISGylating activity of SARS-CoV papain-like protease

Structural insights into the 399 interactions of papain-like protease 2 from the alphacoronavirus porcine epidemic diarrhea virus 400 and ubiquitin

Decoupling deISGylating and deubiquitinating 403 activities of the MERS virus papain-like protease

Irreversible inactivation of 406 ISG15 by a viral leader protease enables alternative infection detection strategies

Ubiquitin-like protein activation by E1 enzymes: the apex for downstream 409 signalling pathways

Structures of the SUMO E1 provide mechanistic insights into SUMO activation and 412 E2 recruitment to E1

Sumoylation of the nucleocapsid protein of severe acute respiratory 415 syndrome coronavirus

SARS-CoV nucleocapsid protein binds to hUbc9, a 418 ubiquitin conjugating enzyme of the sumoylation system

The interaction of animal cytoplasmic RNA viruses with the nucleus to facilitate 421 replication

Sumoylation promotes the stability of the DNA 423 sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus

Coronavirus papain-like proteases 426 negatively regulate antiviral innate immune response through disruption of STING-mediated 427 signaling

Message in a bottle: lessons learned from antagonism of STING 429 signalling during RNA virus infection

Polyubiquitin chain assembly and organization 432 determine the dynamics of protein activation and degradation

SUMO-1 modification activates the 435 transcriptional response of p53

p53 down-regulates SARS 438 coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase 439 RCHY1

SUMO-1 modification of IκBα inhibits NF-κB activation. Mol 441 Cell

Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-444 infected mice increases survival

Decrypting UFMylation: how proteins are modified with UFM1

A cross-kingdom 449 conserved ER-phagy receptor maintains endoplasmic reticulum homeostasis during stress

Double-membrane vesicles as platforms for viral 452 replication. Trends in Microbiol

Influenza A virus induces 454 autophagosomal targeting of ribosomal proteins

UFMylation maintains tumor suppressor p53 457 stability by antagonizing its ubiquitination

UFMylation inhibits the 460 proinflammatory capacity of interferon-γ-activated macrophages

Circuits 463 between infected macrophages and T cells in SARS-CoV-2 pneumonia

ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate 466 antiviral response

Functions and mechanisms of non-histone protein acetylation

Ubiquitin acetylation 474 inhibits polyubiquitin chain elongation

Lysyl oxidase 3 is a dual-specificity enzyme 477 involved in STAT3 deacetylation and deacetylimination modulation

An aberrant STAT pathway is central to 480 COVID-19

SARS-CoV-2 nucleocapsid 485 protein attenuates stress granule formation and alters gene expression via direct interaction with 486 host mRNAs

Arginine methylation of SARS-CoV-2 nucleocapsid protein 488 regulated RNA binding, its ability to suppress stress granule formation, and viral replication

Influenza virus NS1 protein interacts with the 491 cellular 30 kDa subunit of CPSF and inhibits 3' end formation of cellular pre-RNAs. Mol Cell

Identification of a nuclear 494 exosome decay pathway for processed transcripts

Regulation of coronaviral poly(A) tail length during infection. PLOS 497 One

Characterization of the role of hexamer AGUAAA and 499 poly(A) tail in coronavirus polyadenylation

Viral hijacking of the TENT4-ZCCHC14 complex 502 protects viral RNAs via mixed tailing

Ccr4-Not complex: the control freak of eukaryotic cells

2'-O methylation of the viral mRNA cap 507 evades host restriction by IFIT family members

Structural basis of RNA cap modification 510 by SARS-CoV-2

RNA triphosphatase DUSP11 enables 512 exonuclease XRN-mediated restriction of hepatitis C virus

DUSP11-mediated control of 515 5'-triphosphate RNA regulates RIG-I sensitivity

DUSP11 and triphosphate RNA balance during virus infection

A genome-520 wide CRISPR/Cas9 knock-out screen identifies DEAD box RNA helicase DDX42 as a broad antiviral 521 inhibitor

Human endogenous 523 retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associated with 524 early mortality

Inhibition of human endogenous retrovirus-K by 526 antiretroviral drugs

Analysis of the efficacy of HIV protease 529 inhibitors against SARS-CoV-2's main protease

A trial of lopinavir-ritonavir in adults hospitalized 532 with severe COVID-19